Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonsmall Cell Lung Cancer Stage III”

910 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 910 results

Testing effectiveness (Phase 2)Ended earlyNCT02019979
What this trial is testing

Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)

Who this might be right for
Non-small Cell Lung Cancer Stage IIIB/IVNon-small Cell Lung Cancer MetastaticNonsquamous Nonsmall Cell Neoplasm of Lung
Beth Israel Medical Center 14
Testing effectiveness (Phase 2)UnknownNCT02407366
What this trial is testing

Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
People's Hospital of Guangxi Zhuang Autonomous Region 80
Testing effectiveness (Phase 2)Study completedNCT00227539
What this trial is testing

Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Washington 25
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Not applicableLooking for participantsNCT06139627
What this trial is testing

Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy

Who this might be right for
Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8
City of Hope Medical Center 180
Large-scale testing (Phase 3)Study completedNCT04642469
What this trial is testing

Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.

Who this might be right for
Carcinoma, Non- Small Cell Lung
AstraZeneca 30
Early research (Phase 1)WithdrawnNCT00560495
What this trial is testing

Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Not applicableWithdrawnNCT05287971
What this trial is testing

Standard of Care Lifestyle Support for Stage III NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
Maastricht Radiation Oncology
Testing effectiveness (Phase 2)UnknownNCT03672136
What this trial is testing

Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Shandong Cancer Hospital and Institute 25
Large-scale testing (Phase 3)Ended earlyNCT02129699
What this trial is testing

Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy

Who this might be right for
Lung Cancer Non-small Cell Stage IV
ETOP IBCSG Partners Foundation 595
Large-scale testing (Phase 3)UnknownNCT00955695
What this trial is testing

Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Cancer Center, Korea 242
Not applicableNot Yet RecruitingNCT05909137
What this trial is testing

Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

Who this might be right for
ImmunotherapyIntensity Modulated Radiation TherapyRadiotherapy+1 more
Xinqiao Hospital of Chongqing 60
Testing effectiveness (Phase 2)UnknownNCT05338619
What this trial is testing

Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy

Who this might be right for
Non-small Cell Lung Cancer Stage IIIEGFR Positive Non-small Cell Lung CancerNon-squamous Non-small-cell Lung Cancer
Sung Yong Lee 77
Large-scale testing (Phase 3)Study completedNCT02027428
What this trial is testing

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

Who this might be right for
Squamous Cell Carcinoma, Non-Small-Cell Lung
Celgene 427
Testing effectiveness (Phase 2)UnknownNCT04181372
What this trial is testing

Neoadjuvant Chemotherapy Plus Anlotinib in Stage III(N2) Non-small-cell Lung Cancer

Who this might be right for
Stage III Non-small-cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University 50
Large-scale testing (Phase 3)Looking for participantsNCT05624996
What this trial is testing

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaStage IIB Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8
NRG Oncology 474
Testing effectiveness (Phase 2)Study completedNCT00655161
What this trial is testing

A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant S. Cerevisiae Expressing Mutant Ras Protein, as Consolidation Therapy Following Curative Treatment for Stage I-III Non-Small Cell Lung Cancer (NSCLC) With Tumor Sequence Confirmation of K-ras Mutation

Who this might be right for
NSCLC
GlobeImmune 24
Testing effectiveness (Phase 2)UnknownNCT06391008
What this trial is testing

Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer

Who this might be right for
Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 44
Next Page